BOSTON and STOCKHOLM, Aug. 5, 2019 /PRNewswire/ -- Aprea Therapeutics, a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein, today announced the appointment of Scott Coiante as Senior Vice President and

PALO ALTO, Calif., Aug. 5, 2019 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that management will participate in two upcoming investor conferences in August.BTIG Biotechnology Conference at St. Regis Hotel in

PORTLAND, Ore., Aug. 5, 2019 /PRNewswire/ -- Today at Microscopy and Microanalysis 2019, Thermo Fisher Scientific unveiled a new Krios solution designed to break down the barriers to cryo-EM adoption through improved ease-of-use, faster results and the most compact 300kV cryo-EM microscope design on the market. Scientists at leading research institutes and pharma co

WOONSOCKET, R.I., Aug. 5, 2019 /PRNewswire/ -- CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), announced that this week, customers will be able to enroll in CarePass at participating CVS Pharmacy locations nationwide, or online at

CAESAREA, Israel, Aug. 5, 2019 /PRNewswire/ -- IceCure Medical Ltd. (TASE: ICCM), an Israeli medical device company that has developed a minimally-invasive cryoablation technology to treat malignant and benign tumors by freezing without the need for surgery, has received Israeli AMAR authorization for use of its freezing technology in specific indications. The new a

RAMET GAN, Israel, Aug. 5, 2019 /PRNewswire/ -- OWC Pharmaceuticals Research Corp. ("OWC") (OTCQB: OWCP) announced that, on July 18, 2019, it received long-awaited approval from the Israeli Medical Cannabis Agency to perform an efficacy s

HOBOKEN, New Jersey, Aug. 5, 2019 /PRNewswire/ -- Innoplexus, a leader in artificial intelligence (AI) solutions for the life sciences industry, has partnered with the nonprofit Cures Within Reach for Cancer to pave the way for faster and more effective identification of new, affordable cancer treatments among existing non-cancer generic and off-patent

MELBOURNE, Australia and ATLANTA, Aug. 5, 2019 /PRNewswire/ -- Australian patients with diabetes-induced eye disease can now access a new treatment option that provides consistent and continuous treatment with long-lasting effect.The Therapeutic Goods Administration has now approved the drug ILUVIEN® (fluocinolone acetonide intravitreal implant),

SANTA FE, N.M., Aug. 5, 2019 /PRNewswire/ -- Dr. Robyn Benson of Amplified Regenerative Therapies (ART) is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called

JUPITER FARMS, Fla., Aug. 5, 2019 /PRNewswire/ -- Murray Goldberg, MD with Urologic Physicians and Surgeons, PA is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called